Results

Chicago Atlantic BDC Inc.

08/14/2025 | Press release | Distributed by Public on 08/14/2025 05:11

Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)

Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes that are included in Item 1 of Part I of this quarterly report on Form 10-Q. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section entitled "Item 1A. Risk Factors" in our annual report on Form 10-K for the fiscal year ended December 31, 2024 and elsewhere in this quarterly report on Form 10-Q. Please also see the section entitled "Special Note Regarding Forward-Looking Statements."

Overview

We were formed in January 2021 as a Maryland corporation and are structured as an externally managed, closed-end, non-diversified management investment company. We have elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940 (the "1940 Act"). In addition, for U.S. federal income tax purposes we have elected to be treated, and intend to qualify annually to be treated, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code (the "Code"), commencing with our taxable year ended March 31, 2022.

We are a specialty finance company focused on investing in companies in highly complex and highly regulated industries typically underserved by other capital providers, including investing across the cannabis ecosystem through investments in the form of direct loans to privately held cannabis companies. Although we primarily focus on investments in the cannabis industry, we may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities as described further below.

Our investment objective is to maximize risk-adjusted returns on equity for our shareholders. We seek to capitalize on, among other things, what we believe to be nascent cannabis industry growth, and drive return on equity by generating current income from our debt investments and capital appreciation from our equity and equity-related investments. We intend to achieve our investment objective by investing primarily in secured debt, unsecured debt, equity warrants and direct equity investments in privately held businesses. We intend that our debt investments will often be secured by either a first or second priority lien on the assets of the portfolio company, can include either fixed or floating rate terms and will generally have a term of between three and six years from the original investment date. To date, we have been focused on investing in first lien secured, fixed and floating rate debt with terms of two to four years. We expect our secured loans to be secured by various types of assets of our borrowers. While the types of collateral securing any given secured loan will depend on the nature of the borrower's business, common types of collateral we expect to secure our loans include real property and certain personal property, including equipment, inventory, receivables, cash, intellectual property rights and other assets to the extent permitted by applicable laws and the regulations governing our borrowers. Certain attractive assets of our cannabis borrowers, such as cannabis licenses and cannabis inventory, may not be able to be used as collateral or transferred to us. In some of our portfolio investments, we expect to receive nominally priced equity warrants and/or make direct equity investments in connection with a debt investment. In addition, a portion of our portfolio may be comprised of derivatives, including total return swaps.

Generally, the loans we invest in have a complete set of financial maintenance covenants, which are used to proactively address materially adverse changes in a portfolio company's financial performance. However, we may invest in "covenant-lite" loans. We use the term "covenant-lite" to refer generally to loans that do not have a complete set of financial maintenance covenants. Generally, "covenant-lite" loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower's financial condition. Accordingly, to the extent we invest in "covenant-lite" loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with a complete set of financial maintenance covenants.

The loans in which we tend to invest typically pay interest at rates which are determined periodically on the basis of U.S. Prime Rate ("PRIME") or Secured Overnight Financing Rate ("SOFR") plus a premium. The loans in which we have invested and expect to invest are typically made to U.S. and, to a limited extent, non-U.S. (including emerging market) corporations, partnerships and other business entities which operate in various industries and geographical regions. These loans typically are not rated or are rated below investment grade. Securities rated below investment grade are often referred to as "high-yield" or "junk" securities, and may be considered a higher risk than debt instruments that are rated above investment grade.

We have typically invested in and expect to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies with up to $100 million of earnings before interest, taxes, depreciation and amortization, or "EBITDA." Our business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. We expect that our investments will generally range between $2 million and $50 million each, although we expect that this investment size will vary proportionately with the size of our capital base. We have an active pipeline of investments and are currently reviewing approximately $780.3 million of potential investments in varying stages of underwriting.

The following describes the four primary current sub-strategies of our principal investment strategy. We are not required to have a minimum investment in any of these sub-strategies.

Cannabis

All of our cannabis investments are designed to be compliant with all applicable laws and regulations within the jurisdictions in which they are made or to which we are otherwise subject, including U.S. federal laws. We will make equity investments only in companies that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate, including U.S. federal laws. We may make loans to companies that we determine based on our due diligence are licensed in, and complying with, state-regulated cannabis programs, regardless of their status under U.S. federal law, so long as the investment itself is designed to be compliant with all applicable laws and regulations in the jurisdiction in which the investment is made or to which we are otherwise subject, including U.S. federal law. We are externally managed by Chicago Atlantic BDC Advisers, LLC (the "Adviser") and seek to expand the compliant cannabis investment activities of the Adviser's leading investment platform in the cannabis industry. We primarily seek to partner with private equity firms, entrepreneurs, business owners and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and cannabidiol ("CBD") distribution companies. Under normal circumstances, each such cannabis company derives at least 50% of its revenues or profits from, or commits at least 50% of its assets to, activities related to cannabis at the time of our investment in the cannabis company. We are not required to invest a specific percentage of our assets in such cannabis companies, and we may make debt and equity investments in other companies regardless of sector.

The Adviser seeks to invest in cannabis companies that it believes have some or all of the following characteristics:

Growth or EBITDA positive entities
Companies that require capital but do not want to dilute their equity
Companies that are showing strong cash flow performance with low leverage profiles
Transactions that tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry
Low debt to enterprise value

Growth & Technology

Our growth and technology sub-strategy is focused on industry leaders and disruptive companies that are experiencing strong growth trajectories and typically need capital to support continued revenue growth or expansion of the business. In most cases, these businesses have found a niche in their respective markets, proven their customer value proposition, and have already reached significant revenue milestones. These businesses include both private equity and venture capital backed businesses, as well as non-sponsor backed companies. In most cases, a significant amount of equity capital has been raised, resulting in low overall loan to enterprise value.

The Adviser seeks to invest in growth and technology focused companies that it believes have some or all of the following characteristics:

Industry leaders and disruptive companies experiencing strong growth
Companies that have raised significant equity capital validating market value
Industry focus typically includes software, hardware, e-commerce, direct to consumer and other fast-growing companies
Liquidity covenants that ensure such company has adequate cash runway
Low debt to enterprise value
Profitable or demonstrated path to near term profitability

Esoteric & Asset-Based Lending

The esoteric and asset-based lending sub-strategy is focused on established companies with strong cash flow profiles in industries that carry idiosyncratic or reputational risks, which limit access to traditional sources of capital. The sub-strategy also includes companies or opportunities that have strong asset collateral coverage, low loan values or other attractive risk-reward features. The lack of access to traditional sources of capital typically enables us to extract lender-friendly terms and covenants from companies with relatively low leverage and overall credit risk.

The Adviser seeks to invest in esoteric industries or companies in need of asset-based loans that it believes have some or all of the following characteristics:

Companies that are showing strong cash flow performance with low leverage profiles, but the industries carry regulatory, reputational or other risks
Companies with attractive assets, including, but not limited to, accounts receivable, equipment or real estate
Transactions that tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry or situation
Low debt to asset value and/or enterprise value ratios

Liquidity Solutions

The liquidity solutions lending sub-strategy is typically focused on event-driven opportunities including, but not limited to, mergers, acquisitions, refinancings, dividend recaps or other strategically driven liquidity needs to established businesses. These businesses also tend to be in complex industries, have time-sensitive aspects to financing, or require idiosyncratic structuring expertise that enables us to extract relatively lender friendly terms and covenants.

The Adviser seeks to invest in liquidity solutions opportunities that it believes have some or all of the following characteristics:

Financing is typically event driven
Companies that are pursuing a merger, acquisition, refinancing, dividend recap, or other strategic liquidity need
Companies that are showing strong cash flow performance with low leverage profiles
Companies that have multiple areas of value and liquidity in addition to the underlying business
Low debt to enterprise value ratios

None of our investment policies are fundamental, and thus may be changed without stockholder approval.

We are externally managed by the Adviser. The Adviser also provides the administrative services necessary for us to operate. We believe that our ability to leverage the existing investment management platform of Chicago Atlantic enables us to operate more efficiently and with lower overhead costs than other funds of comparable size.

Revenues

We generate revenues primarily in the form of interest income from the investments we hold. In addition, we may generate income from dividends on either direct equity investments or equity interests obtained in connection with originating loans, such as options, warrants or conversion rights. Our debt investments typically have a term of two to six years. Our loan portfolio will bear interest at a fixed or floating rate, subject to interest rate floors in certain cases. Interest on our debt investments will generally be payable either monthly or quarterly, but may be semi-annually.

Our investment portfolio consists of fixed and floating rate loans, and our revolving credit facility also bears interest at a floating rate, when drawn. Macro trends in base interest rates like PRIME or SOFR may affect our net investment income (loss) over the long term.

We accrete premiums or amortize discounts into interest income using the effective yield method for term instruments. Repayments of our debt investments will reduce interest income in future periods. The frequency or volume of these repayments may fluctuate significantly. We will record prepayment premiums on loans as interest income. We may also generate revenue in the form of commitment, structuring, or due diligence fees, fees for providing managerial assistance to our portfolio companies, and consulting fees.

Dividend income on equity investments, if applicable, will be recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded companies.

Our portfolio activity may also reflect the proceeds from sales of investments. We will recognize realized gains or losses on sales of investments based on the difference between the net proceeds from the disposition and the amortized cost basis of the investment, without regard to unrealized gains or losses previously recognized. We will record current-period changes in fair value of investments that are measured at fair value as a component of the net change in unrealized gains (losses) on investments on the Statements of Operations.

Expenses

Our primary operating expenses are a base management fee and any incentive fees under the investment advisory agreement between the Company and the Adviser (the "Investment Advisory Agreement"). Our investment management fee compensates our Adviser for its work in identifying, evaluating, negotiating, executing, monitoring, servicing and realizing our investments. See "Item 1. Business-Investment Advisory Agreement."

Except as specifically provided below, all investment professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory and management services to us, the base compensation, bonus and benefits, and the routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Adviser. We may bear our allocable portion of the compensation paid by the Adviser (or its affiliates) to our Chief Financial Officer ("CFO") and Chief Compliance Officer ("CCO") and their respective staffs (based on a percentage of time such individuals devote, on an estimated basis, to our business affairs). We may bear any other expenses of our operations and transactions, including (without limitation) fees and expenses relating to:

the cost of our organization and offerings;
the cost of calculating our net asset value, including the cost of any third-party valuation services;
the cost of effecting sales and repurchases of shares of our common stock and other securities;
fees and expenses payable under any underwriting agreements, if any;
debt service and other costs of borrowings or other financing arrangements;
costs of hedging;
expenses, including travel expenses, incurred by the Adviser, or members of the investment team, or payable to third-parties, performing due diligence on prospective portfolio companies and, if necessary, enforcing our rights;
management and incentive fees payable pursuant to the Investment Advisory Agreement;
fees payable to third-parties relating to, or associated with, making investments and valuing investments (including third-party valuation firms);
costs, including legal fees, associated with compliance under cannabis laws;
transfer agent and custodial fees;
fees and expenses associated with marketing efforts (including attendance at industry and investor conferences and similar events);
federal and state registration fees;
any exchange listing fees and fees payable to rating agencies;
federal, state and local taxes;
independent directors' fees and expenses, including travel expenses;
cost of preparing financial statements and maintaining books and records and filing reports or other documents with the SEC (or other regulatory bodies) and other reporting and compliance costs, and the compensation of professionals responsible for the preparation of the foregoing;
the cost of any reports, proxy statements or other notices to our stockholders (including printing and mailing costs), the costs of any stockholder or director meetings and the compensation of investor relations personnel responsible for the preparation of the foregoing and related matters;
brokerage commissions and other compensation payable to brokers or dealers;
research and market data;
fidelity bond, directors' and officers' errors and omissions liability insurance and other insurance premiums;
direct costs and expenses of administration, including printing, mailing and staff;
fees and expenses associated with independent audits, and outside legal and consulting costs;
costs of winding up;
costs incurred in connection with the formation or maintenance of entities or vehicles to hold our assets for tax or other purposes;
extraordinary expenses (such as litigation or indemnification); and
costs associated with reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws.

We expect, but cannot assure, that our general and administrative expenses will increase in dollar terms during periods of asset growth, but will decline as a percentage of total assets during such periods.

Hedging

To the extent that any of our investments are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of futures, options, swaps and forward contracts. Costs incurred in entering into such contracts or in connection with settling them will be borne by us.

Portfolio Composition and Investment Activity

Portfolio Composition

As of June 30, 2025, our investment portfolio had an aggregate fair value of approximately $307.5 million and was comprised of approximately $267.6 million in first lien, senior secured loans, approximately $38.9 million in senior secured notes and approximately $1.0 million in equity securities across thirty-three portfolio companies. As of December 31, 2024, our investment portfolio had an aggregate fair value of approximately $275.2 million and was comprised of approximately $239.9 million in first lien, senior secured loans, approximately $34.7 million in senior secured notes and $0.7 million in equity securities across twenty-eight portfolio companies.

A summary of the composition of our investment portfolio at amortized cost and fair value as a percentage of total investments as of June 30, 2025 and December 31, 2024 are shown in the following tables.

As of June 30, 2025

Investment Type

Amortized Cost

Fair Value

First Lien Senior Secured Loans

87.0

%

87.0

%

Senior Secured Notes

12.6

%

12.6

%

Preferred Stock

0.2

%

0.2

%

Warrants

0.2

%

0.2

%

Total

100.0

%

100.0

%

As of December 31, 2024

Investment Type

Amortized Cost

Fair Value

First Lien Senior Secured Loans

87.1

%

87.1

%

Senior Secured Notes

12.6

%

12.6

%

Preferred Stock

0.2

%

0.2

%

Warrants

0.1

%

0.1

%

Total

100.0

%

100.0

%

The following tables show the composition of our investment portfolio by geographic region of the United States at amortized cost and fair value as a percentage of total investments as of June 30, 2025 and December 31, 2024. The geographic composition is determined by the location of the headquarters of the portfolio company.

Geographic regions are defined as: West, for the states of WA, OR, ID, MT, WY, CO, AK, HI, UT, NV and CA; Midwest, for the states of ND, SD, NE, KS, MO, IA, MN, WI, MI, IL, IN and OH; Northeast, for the states of PA, NJ, NY, CT, RI, MA, VT, NH and ME; Southeast, for the states of AR, LA, MS, TN, KY, AL, FL, GA, SC, NC, VA, DE, WV and MD; and Southwest, for the states of AZ, NM, TX and OK.

As of June 30, 2025

Geographic Region

Amortized Cost

Fair Value

United States:

Midwest

34.6

%

34.5

%

West

29.4

%

29.5

%

Northeast

18.0

%

18.1

%

Southeast

9.8

%

9.8

%

Southwest

7.2

%

7.2

%

International:

Canada

1.0

%

1.0

%

Total

100.0

%

100.0

%

As of December 31, 2024

Geographic Region

Amortized Cost

Fair Value

United States:

Midwest

32.4

%

32.6

%

West

31.6

%

31.5

%

Northeast

19.3

%

19.3

%

Southwest

8.0

%

8.0

%

Southeast

7.6

%

7.5

%

International:

Canada

1.1

%

1.1

%

Total

100.0

%

100.0

%

The tables below present the industry composition of our investment portfolio at amortized cost and fair value as a percentage of total investments as of June 30, 2025 and December 31, 2024.

As of June 30, 2025

Industry(1)

Amortized Cost

Fair Value

Cannabis

78.4

%

78.5

%

Finance and Insurance

9.4

%

9.4

%

Public Administration

3.8

%

3.8

%

Information

3.9

%

3.9

%

Retail Trade

3.6

%

3.6

%

Real Estate and Rental and Leasing

0.9

%

0.8

%

Total

100.0

%

100.0

%

As of December 31, 2024

Industry(1)

Amortized Cost

Fair Value

Cannabis

76.6

%

76.7

%

Finance and Insurance

11.3

%

11.2

%

Information

5.4

%

5.4

%

Public Administration

3.7

%

3.8

%

Retail Trade

1.2

%

1.2

%

Health Care and Social Assistance

1.0

%

1.0

%

Real Estate and Rental and Leasing

0.8

%

0.7

%

Total

100.0

%

100.0

%

(1)
The Company uses the North American Industry Classification System ("NAICS") code for classifying the industry grouping of its portfolio companies, excluding any portfolio company operating in the cannabis industry.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment's carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of June 30, 2025 and December 31, 2024, we had three portfolio companies that represented 39.5% and 45.1% respectively, of our investments, at fair value. As of June 30, 2025 and December 31, 2024, our largest portfolio company represented 16.8% and 18.9%, respectively, of our investments, at fair value.

Investment Activity

The following table provides a summary of the changes in the investment portfolio for the six months ended June 30, 2025 and 2024:

For the Six Months Ended

June 30, 2025

June 30, 2024

Beginning Portfolio, at fair value

$

275,241,398

$

54,120,000

Purchases

59,050,605

1,575,000

Accretion of discount and fees (amortization of premium), net

1,216,102

349,179

PIK interest

1,045,967

113,137

Proceeds from sales of investments and principal repayments

(29,940,662

)

(3,126,000

)

Net realized gain (loss) on investments

-

-

Net change in unrealized appreciation (depreciation) on investments

885,594

366,848

Ending Portfolio, at fair value

$

307,499,004

$

53,398,164

Portfolio Asset Quality

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our Adviser's valuation committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Company's Board of Directors (the "Board") and the Audit Committee of the Board.

Investment
Performance
Risk Rating

Summary Description

Grade 1

Investments rated 1 involve the least amount of risk to our initial cost basis. The borrower is performing above expectations, and the trends and risk factors for this investment since origination or acquisition are generally favorable. Full return of principal, interest and dividend income is expected.

Grade 2

Investment is performing in-line with expectations. Investments rated 2 involve an acceptable level of risk that is similar to the risk at the time of origination or acquisition. Risk factors remain neutral or favorable compared with initial underwriting. All investments or acquired investments in new portfolio companies are initially assessed a rating of 2.

Grade 3

Investments rated 3 involve a borrower performing below expectations and indicates that the loan's risk has increased somewhat since origination or acquisition. Capital impairment or payment delinquency is not anticipated. The investment may also be out of compliance with certain financial covenants.

Grade 4

Investments rated 4 involve a borrower performing materially below expectations and indicates that the loan's risk has increased materially since origination or acquisition. In addition to the borrower being generally out of compliance with debt covenants, loan payments may be past due (but generally not more than 120 days past due). Delinquency of interest and / or dividend payments in anticipated. No loss of principal is anticipated.

Grade 5

Investments rated 5 involve a borrower performing substantially below expectations and indicates that the loan's risk has increased substantially since origination or acquisition. It is anticipated that the Company will not recoup its initial cost and may realize a loss upon exit. Most or all of the debt covenants are out of compliance and payments are substantially delinquent. Loans rated 5 are not anticipated to be repaid in full and we will reduce the fair market value of the loan to the amount we anticipate will be recovered.

The following tables show the distribution of our loan investments on the 1 to 5 investment risk rating scale at fair value as of June 30, 2025 and December 31, 2024:

As of June 30, 2025

Investment Performance Risk Rating

Investments
at Fair
Value

Percentage
of Total
Investments

1

$

-

0.0

%

2

307,499,004

100.0

%

3

-

0.0

%

4

-

0.0

%

5

-

0.0

%

Total

$

307,499,004

100.0

%

As of December 31, 2024

Investment Performance Risk Rating

Investments
at Fair
Value

Percentage
of Total
Investments

1

$

-

0.0

%

2

275,241,398

100.0

%

3

-

0.0

%

4

-

0.0

%

5

-

0.0

%

Total

$

275,241,398

100.0

%

Debt Investments on Non-Accrual Status

As of June 30, 2025 and December 31, 2024, there were no loans in our portfolio placed on non-accrual status.

Debt

Revolving Line of Credit

On February 11, 2025, the Company entered into a senior secured revolving credit agreement (the "Credit Agreement", the "Revolving Line of Credit") by and among the Company, as borrower, Western Alliance Trust Company, N.A. ("WATC"), as administrative agent, Western Alliance Bank, as an issuing bank and as the initial lender, and the other lenders party thereto from time to time.

Under the Credit Agreement, the lenders have agreed to extend credit to the Company on a revolving basis in an initial aggregate amount of up to $100,000,000 with an option for the Company to request additional commitments, in a minimum amount of $5,000,000, at one or more times from existing and/or new lenders. The Credit Agreement also provides for the issuance of letters of credit in an aggregate face amount of up to $5,000,000.

Availability under the Credit Agreement (the "Revolving Period") will terminate on February 11, 2027, and the Credit Agreement has a scheduled maturity date of March 31, 2028.

As of June 30, 2025, the Company had $5,000,000 outstanding borrowings and $95,000,000 available under the Revolving Line of Credit. Additionally, as of June 30, 2025, $233.9 million of loans held for investment, at principal, were pledged as collateral in the borrowing base of the Revolving Loan.

Results of Operations

The following discussion and analysis of our results of operations encompasses our results for the three and six months ended June 30, 2025 and 2024.

Investment Income

The following table sets forth the components of investment income for the three and six months ended June 30, 2025 and 2024:

For the Three Months Ended

For the Six Months Ended

June 30, 2025

June 30, 2024

June 30, 2025

June 30, 2024

Stated interest income

$

10,616,576

$

2,522,397

$

20,799,750

$

5,054,514

Accretion of discount and fees (amortization of premium), net

693,195

207,750

1,216,102

349,179

PIK

596,295

60,186

1,169,670

113,137

Total interest income

11,906,066

2,790,333

23,185,522

5,516,830

Fee income

1,173,972

291,000

1,817,518

324,750

Total investment income

$

13,080,038

$

3,081,333

$

25,003,040

$

5,841,580

We generate revenues primarily in the form of investment income from the investments we hold, generally in the form of interest income from our debt securities. We also generate revenues in the form of investment income from the cash we hold, generally in the form of interest income from our investment in a money market fund. Stated interest income represents interest income recognized as earned in accordance with the contractual terms of the loan agreement. Stated interest income from original issue discount ("OID") and market discount represent the accretion into interest income over the term of the loan as a yield enhancement. Interest income from payment-in-kind ("PIK") represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

The Company also recognizes certain fees as one-time fee income, including, but not limited to, structuring fees.

For the three and six months ended June 30, 2025, total investment income was approximately $13.1 million and $25.0 million, respectively, which was attributable to $1.2 million and $1.8 million of fee income related to commitment fees, success fees, amendment fees and administrative fees and approximately $11.9 million and $23.2 million of interest income, respectively. For the three and six months ended June 30, 2024, total investment income was approximately $3.1 million and $5.8 million, respectively, which was attributable to approximately $0.3 million and $0.3 million of fee income related to commitment fees, advisory fees, and administrative fees and approximately $2.8 million and $5.5 million of interest income, respectively.

Operating Expenses

Our operating expenses for the six months ended June 30, 2025 and 2024 are presented below:

For the Six Months Ended

June 30, 2025

June 30, 2024

$ Change

% Change

Income-based incentive fees

$

3,884,914

$

328,503

$

3,556,411

1082.6%

Management fee

2,606,206

492,455

2,113,751

429.2%

General and administrative expense

2,341,260

-

2,341,260

100.0%

Legal expenses

564,065

139,873

424,192

303.3%

Professional fees

491,586

120,136

371,450

309.2%

Interest expense

446,641

-

446,641

100.0%

Audit expense

343,752

203,550

140,202

68.9%

Other expenses

314,139

199,158

114,981

57.7%

Sub-administrator fees

286,590

199,643

86,947

43.6%

Capital gains incentive fees

177,119

73,369

103,750

141.4%

Transaction expenses related to the Loan Portfolio Acquisition

-

2,639,069

(2,639,069

)

-100.0%

Total operating expenses

11,456,272

4,395,756

7,060,516

160.6%

Waiver of General and administrative expense (Note 6)

(658,477

)

-

(658,477

)

-100.0%

Expense limitation agreement (Note 6)

(1,107,783

)

-

(1,107,783

)

-100.0%

Net operating expenses

$

9,690,012

$

4,395,756

$

5,294,256

120.4%

Net Investment Income

Net investment income was approximately $7.7 million and $15.3 million for the three and six months ended June 30, 2025, respectively, as compared to approximately $1.5 million and $1.4 million for the three and six months ended June 30, 2024, respectively. The fluctuation in net investment income is attributable to the increase in complexity, portfolio size and growth of the Company following the close of the previously announced acquisition of a portfolio of loans (the "Loan Portfolio") from Chicago Atlantic Loan Portfolio, LLC ("CALP") in exchange for newly issued shares of the Company's common stock (the "Loan Portfolio Acquisition"). The amortized cost of the Company's investment portfolio increased by $253.3 million from June 30, 2024 to June 30, 2025.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the amortized cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period. There were no net realized gains or losses from investments during the three and six months ended June 30, 2025 and 2024.

Net Change in Unrealized Appreciation (Depreciation) from Investments

Net change in unrealized appreciation (depreciation) from investments primarily reflects the net change in the fair value as of the last business day of the reporting period, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period. We record current-period changes in fair value of investments that are measured at fair value as a component of the net change in unrealized appreciation (depreciation) on investments on the Statements of Operations.

Net change in unrealized appreciation (depreciation) from investments for the three and six months ended June 30, 2025 and 2024 is comprised of the following:

For the Three Months Ended

For the Six Months Ended

June 30, 2025

June 30, 2024

June 30, 2025

June 30, 2024

Gross unrealized appreciation

$

1,428,075

$

190,134

$

1,553,712

$

389,573

Gross unrealized depreciation

(508,417

)

(422,906

)

(668,118

)

(22,725

)

Total net change in unrealized appreciation (depreciation) from investments

$

919,658

$

(232,772

)

$

885,594

$

366,848

The following table details net change in unrealized appreciation (depreciation) for our portfolio for the three and six months ended June 30, 2025 and 2024:

For the Three Months Ended

For the Six Months Ended

June 30, 2025

June 30, 2024

June 30, 2025

June 30, 2024

Aeriz Holdings Corp

$

121,039

$

-

$

53,418

$

-

Archos Capital Group, LLC

255

-

255

-

Ascend Wellness

58,604

-

84,425

-

Aura Home, Inc

(63,591

)

-

22,707

-

Cannabis & Glass (Kapple Holdings LLC)

18,489

-

18,440

-

Curaleaf Holdings, Inc.

207,714

(36,964

)

211,587

(5,519

)

Deep Roots Harvest, Inc.

797,813

-

822,813

-

Dreamfields Brands, Inc. (d/b/a Jeeter)

(20,800

)

(8,730

)

(36,720

)

(17,206

)

Elevation Cannabis, LLC

2,663

-

(112,185

)

-

Flowery - Bill's Nursery, Inc.

(17,934

)

-

(33,580

)

-

Fluent Corp. (f/k/a Consortium)

(11,661

)

-

1,449

-

HA-MD, LLC

(831

)

-

(1,453

)

-

Hartford Gold Group, LLC: (Maturity: 1/6/2027)

(72,170

)

-

(30,004

)

-

Hartford Gold Group, LLC: (Maturity: 12/17/2025)

-

-

(12,063

)

-

Kaleafa, Inc.

(431

)

-

28,319

-

Minden Holdings, LLC

(1,896

)

-

(2,450

)

-

Nova Farms, LLC

(83,199

)

-

(107,432

)

-

Oasis - AZ GOAT AZ LLC

(16,565

)

-

(28,177

)

-

PharmaCann, Inc.

-

21,134

-

41,282

Proper Holdings, LLC

(694

)

-

(1,543

)

-

Protect Animals With Satellites LLC (Halo Collar): Term Loan

34,273

-

37,982

-

Protect Animals With Satellites LLC (Halo Collar): Incremental Term Loan

18,067

-

21,232

-

Remedy - Maryland Wellness, LLC

(12,172

)

-

(6,104

)

-

RTCP, LLC

3,790

-

2,417

-

Silver Therapeutics, Inc.

(87,300

)

-

(87,300

)

-

Simspace Corporation

51,430

-

72,959

-

STIIIZY, Inc. (f/k/a Shryne Group Inc.)

26,093

(251,788

)

(10,994

)

131,680

Subsero Holdings - Illinois, Inc

14,675

-

48,401

-

Sunny Days Enterprises, LLC

-

-

(43,094

)

-

TheraTrue, Inc.

(14,928

)

-

(14,928

)

-

Tulip.io Inc.

17,788

-

30,144

-

Verano Holdings Corp.

7,357

(125,424

)

5,316

47,611

West Creek Financial Holdings, Inc. dba Koalafi

23,407

-

72,076

-

Workbox Holdings Inc.

24,618

169,000

(16,376

)

169,000

Workbox Holdings Inc.: A-3 Warrants

(24,000

)

-

(40,000

)

-

Workbox Holdings Inc.:A-4 Warrants

(62,715

)

-

(83,715

)

-

Youth Opportunity Investments, LLC

(17,530

)

-

19,772

-

Total net change in unrealized appreciation (depreciation) from investments

$

919,658

$

(232,772

)

$

885,594

$

366,848

Financial Condition, Liquidity and Capital Resources

We generate cash primarily from the net proceeds of offerings of securities and cash flows from operations, including interest earned from the temporary investment of cash in U.S. government securities.

In addition, we have entered into a revolving credit facility. The amount of leverage that we employ will depend on our assessment of market conditions and other factors at the time of any proposed borrowing, such as the maturity, covenant package and rate structure of

the proposed borrowings, our ability to raise funds through the issuance of shares of our common stock and the risks of such borrowings within the context of our investment outlook. Ultimately, we only intend to use leverage if the expected returns from borrowing to make investments will exceed the cost of such borrowing.

Our primary use of funds will be investments in portfolio companies, dividend payments to holders of our common stock who opt out of the Company's dividend reinvestment plan (the "DRIP"), and the payment of operating expenses. As of June 30, 2025 and December 31, 2024, we had cash and cash equivalents of approximately $13.8 million and $23.9 million, respectively, and no indebtedness.

To maintain its tax treatment as a RIC, the Company must meet specified source-of-income requirements and timely distribute to its stockholders for each taxable year at least 90% of its investment company taxable income. Additionally, in order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years.

Dividends may also be distributed in accordance with the DRIP, which provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not "opted out" of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company's common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator.

U.S. Federal Income Taxes

We elected to be treated, and intend to qualify annually to be treated, as a RIC under Subchapter M of the Code for federal income tax purposes. As a RIC, we generally will not have to pay corporate-level federal income taxes on any ordinary income or capital gains that we distribute to our stockholders from our tax earnings and profits. To obtain and maintain our RIC tax treatment, we must, among other things, meet specified source-of-income and asset diversification requirements and distribute annually at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any.

Critical Accounting Estimates

Basis of Presentation

The Company's financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") and pursuant to Regulation S-X under the Securities Act of 1933, as amended (the "Securities Act"). The Company follows accounting and reporting guidance as determined by the Financial Accounting Standards Board ("FASB") Topic 946 Financial Services - Investment Companies.

The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions affecting amounts reported in our financial statements. We will continuously evaluate our estimates, including those related to the matters described below. These estimates will be based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. For additional information, please refer to "Note 2 - Significant Accounting Policies" in the notes to the financial statements included with this quarterly report on Form 10-Q. Valuation of investments is considered to be our critical accounting policy and estimates. A discussion of our critical accounting estimates follows.

Investment Valuation

Investments for which market quotations are readily available will typically be valued at the bid price of those market quotations. To validate market quotations, we utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations. Debt and equity securities that are not publicly traded or whose market prices are not readily available are valued at fair value as determined in good faith by the Adviser, as the Company's valuation designee (the "Valuation Designee"), based on inputs that may include valuations, or ranges of valuations, provided by independent third-party valuation firm(s) engaged by the Adviser. Pursuant to Rule 2a-5 under the 1940 Act, the Board designated the Adviser as the Valuation Designee to perform the fair value determinations for the Company, subject to the oversight of the Board and certain Board reporting and other requirements.

As part of the valuation process, the Adviser takes into account relevant factors in determining the fair value of our investments, including: the estimated enterprise value of a portfolio company (i.e., the total fair value of the portfolio company's debt and equity), the nature and realizable value of any collateral, the portfolio company's ability to make payments based on its earnings and cash flow,

the markets in which the portfolio company does business, a comparison of the portfolio company's securities to any similar publicly traded securities, and overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Adviser considers whether the pricing indicated by the external event corroborates its valuation.

The Adviser undertakes a multi-step valuation process, which includes, among other procedures, the following:

With respect to investments for which market quotations are readily available, those investments will typically be valued at the bid price of those market quotations;
With respect to investments for which market quotations are not readily available, the valuation process begins with the Adviser's valuation committee establishing a preliminary valuation of each investment, which may be based on valuations, or ranges of valuations, provided by independent valuation firm(s);
Preliminary valuations are documented and discussed by the Adviser's valuation committee and, where appropriate, the independent valuation firm(s); and
The Adviser determines the fair value of each investment.

We conduct this valuation process on a quarterly basis.

We apply Accounting Standards Codification ("ASC") 820, Fair Value Measurement ("ASC 820"), which establishes a framework for measuring fair value in accordance with U.S. GAAP and required disclosures of fair value measurements. ASC 820 determines fair value to be the price that would be received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market (which may be a hypothetical market) that are independent, knowledgeable, and willing and able to transact. In accordance with ASC 820, we consider the principal market to be the market that has the greatest volume and level of activity. ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in determination of fair value. In accordance with ASC 820, these levels are summarized below:

Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date;
Level 2 - Valuations based on quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or for which all significant inputs are observable, either directly or indirectly; and
Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

All of our investments as of June 30, 2025 and December 31, 2024 were categorized at Level 3, and therefore, 100% of our portfolio requires significant estimates. Our investments may not have readily available market quotations (as such term is defined in Rule 2a-5 under the 1940 Act), and those investments which do not have readily available market quotations are valued at fair value as determined in good faith in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Significant unobservable inputs create uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company's investments may vary and may include the debt investments' yield and volatility fluctuations. Significant increases (decreases) in discount rate in isolation would result in a significantly lower (higher) fair value assessment. Significant increases (decreases) in volatility in isolation would result in a significantly lower (higher) fair value assessment.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If we were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material.

In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected previously.

Assumptions, or unobservable inputs, fluctuate based on both market and company specific factors. Please refer to "Note 4 - Fair Value of Financial Instruments" in the notes to the financial statements included with this quarterly report on Form 10-Q for specific unobservable inputs.

Other Contractual Obligations

We have certain commitments pursuant to our Investment Advisory Agreement. We have agreed to pay a fee for investment advisory services consisting of two components: a base management fee and an incentive fee. Payments under the Investment Advisory Agreement will be equal to (1) a percentage of the value of our average gross assets and (2) a two-part incentive fee. See "Item 1. Business-Investment Advisory Agreement." We have also entered into a contract with the Adviser to serve as our administrator. Payments under the administration agreement between the Company and the Adviser (the "Administration Agreement") will be reimbursements to the Adviser for the costs and expenses incurred by the Adviser in performing its obligations, including but not limited to maintaining and keeping all books and records and providing personnel and facilities. This includes costs and expenses incurred by the Adviser in connection with the delegation of its obligations to a sub-administrator. The Company is not responsible for the compensation of the Adviser's employees and overhead expenses. See "Item 1. Business-Administration Agreement."

Common Stock

Our common stock began trading on the Nasdaq Global Market on February 4, 2022 in connection with our initial public offering of shares of our common stock. Since October 2, 2024, our common stock trades on the Nasdaq Global Market under the symbol "LIEN."

The following table lists the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on the Nasdaq Global Market, the closing sale prices as a premium (or discount) to our net asset value per share and dividends per share for each fiscal quarter since our common stock began trading on the Nasdaq Global Market. On August 13, 2025, the last reported closing sales price of our common stock on the Nasdaq Global Market was $10.41 per share, which represented a discount of approximately 21.32% to our net asset value per share of $13.23 as of June 30, 2025.

Price Range

High Sales
Price
Premium
(Discount)
to

Low Sales
Price
Premium
(Discount)
to

Cash

Class and Period

Net Asset
Value
(1)

High

Low

Net Asset
Value
(2)

Net Asset
Value
(2)

Dividend
Per Share
(3)

Year Ended December 31, 2025

Third Quarter (Through August 13, 2025)

*

$

10.86

$

10.12

*

*

*

Second Quarter

$

13.23

$

11.11

$

9.71

-16.0

%

-26.6

%

$

0.34

First Quarter

$

13.19

$

12.56

$

10.92

-4.8

%

-17.2

%

$

0.34

Year Ended December 31, 2024

Fourth Quarter

$

13.20

$

13.24

$

10.74

0.3

%

-18.7

%

$

0.34

Third Quarter

$

13.28

$

12.00

$

10.64

-9.6

%

-19.9

%

$

0.25

Second Quarter

$

13.56

$

12.38

$

9.61

-8.7

%

-29.1

%

$

0.25

First Quarter

$

13.60

$

10.28

$

7.65

-24.4

%

-43.8

%

$

0.25

Year Ended December 31, 2023

Fourth Quarter

$

13.77

$

9.81

$

8.32

-28.8

%

-39.6

%

0.70(6)

Third Quarter

$

14.06

$

10.37

$

7.65

-26.3

%

-45.6

%

0.63(6)

Second Quarter

$

14.49

$

9.19

$

7.82

-36.3

%

-45.8

%

First Quarter

$

14.29

$

9.98

$

8.25

-30.2

%

-42.3

%

Year Ended December 31, 2022(4)

Fourth Quarter

$

13.91

$

10.55

$

9.57

-24.2

%

-31.2

%

-

Third Quarter

$

13.73

$

10.74

$

9.00

-21.8

%

-34.5

%

-

Second Quarter

$

13.64

$

13.50

$

7.80

-1.0

%

-42.8

%

-

First Quarter(5)

$

13.61

$

14.41

$

12.57

5.9

%

-7.6

%

-

(1)
Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.
(2)
Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the end of the applicable quarter).
(3)
Represents the dividend or distribution declared in the relevant quarter.
(4)
On November 8, 2022, our Board approved a change to our fiscal year end from March 31 to December 31.
(5)
Shares of our common stock began trading on the Nasdaq Global Market on February 4, 2022. Since October 2, 2024, our common stock trades on the Nasdaq Global Market under the symbol "LIEN."
(6)
Consists of a quarterly dividend and a special dividend.

* Not determined at time of filing.

Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. At times, our shares of common stock have traded at prices both above and below our net asset value per share. The possibility that our shares of common stock will trade at a discount from net asset value per share or at premiums that are unsustainable over the long term are separate and distinct from the risk that our net asset value per share will decrease. It is not possible to predict whether our common stock will trade at, above, or below net asset value per share.

Holders

As of August 12, 2025, there were approximately 285 holders of record of our common stock, which does not include stockholders for whom shares are held in "nominee" or "street name."

Distributions

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of our Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as our Board may deem relevant from time to time.

We have elected to be treated, and intend to qualify annually to be treated, as a RIC under Subchapter M of the Code, for U.S. federal income tax purposes, commencing with our taxable year ended March 31, 2022. As long as we qualify as a RIC, we will not be taxed on our investment company taxable income or realized net capital gains, to the extent that such taxable income or gains are distributed, or deemed to be distributed, to stockholders on a timely basis.

To obtain and maintain RIC tax treatment, we must distribute (or be deemed to distribute) at least 90% of the sum of our: investment company taxable income (which is generally our ordinary income plus the excess of realized short-term capital gains over realized net long-term capital losses), determined without regard to the deduction for dividends paid, for such taxable year; and net tax-exempt interest income (which is the excess of our gross tax-exempt interest income over certain disallowed deductions) for such taxable year.

As a RIC, we (but not our stockholders) generally will not be subject to U.S. federal tax on investment company taxable income and net capital gains that we distribute to our stockholders. The discussion below assumes that we will qualify to be treated as a RIC for U.S. federal tax purposes each year.

We intend to distribute annually all or substantially all of such income. To the extent that we retain our net capital gains or any investment company taxable income, we generally will be subject to corporate-level U.S. federal income tax. We can be expected to carry forward our net capital gains or any investment company taxable income in excess of current-year dividend distributions, and pay the U.S. federal excise tax as described below.

Depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current-year distributions into the next tax year. We will be subject to a 4% excise tax on a certain portion of these undistributed amounts. Please refer to "Item 1. Business - Material U.S. Federal Income Tax Considerations" for further information regarding the consequences of our retention of net capital gains. We may, in the future, make actual distributions to our stockholders of our net capital gains. We can offer no assurance that we will achieve results that will permit the payment of any cash distributions and, if we issue senior securities, we may be prohibited from making distributions if doing so causes us to fail to maintain the asset coverage ratios stipulated by the 1940 Act or if distributions are limited by the terms of any of our borrowings. See "Item 1. Business - Business Development Company Regulations" and "Item 1. Business -Material U.S. Federal Income Tax Considerations."

While we intend to distribute any income and capital gains in the manner necessary to minimize imposition of the 4% U.S. federal excise tax, sufficient amounts of our taxable income and capital gains may not be distributed and as a result, in such cases, the excise tax will

be imposed. In such an event, we will be liable for this tax only on the amount by which we do not meet the foregoing distribution requirement.

To the extent our current taxable earnings for a year fall below the total amount of our distributions for that year, a portion of those distributions may be deemed a return of capital to our stockholders for U.S. federal income tax purposes. Thus, the source of a distribution to our stockholders may be the original capital invested by the stockholder rather than our income or gains. Stockholders should read written disclosure carefully and should not assume that the source of any distribution is our ordinary income or gains.

A return of capital is a return of a portion of your original investment in shares of our common stock. As a result, a return of capital will (i) lower your tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares and (ii) reduce the amount of funds we have for investment in portfolio companies. We have not established any limit on the extent to which we may use offering proceeds to fund distributions. However, our Board, including a majority of our independent directors, will be required to determine that making return of capital distributions from our offering proceeds is in the best interests of our stockholders based upon our then-current financial condition and our expected future growth prospects.

The following table summarizes distributions declared and/or paid by the Company from inception through June 30, 2025:

Declaration Date

Type

Record Date

Payment Date

Per Share
Amount

Dividends Paid

August 10, 2023

Quarterly

September 15, 2023

September 29, 2023

$

0.23

$

1,429,375

August 10, 2023

Special

September 15, 2023

September 29, 2023

$

0.40

$

2,485,869

November 9, 2023

Quarterly

December 20, 2023

December 29, 2023

$

0.25

$

1,553,676

November 9, 2023

Special

December 20, 2023

December 29, 2023

$

0.45

$

2,796,617

March 8, 2024

Quarterly

March 20, 2024

March 28, 2024

$

0.25

$

1,553,736

May 9, 2024

Quarterly

June 20, 2024

June 28, 2024

$

0.25

$

1,553,738

August 8, 2024

Quarterly

September 19, 2024

September 27, 2024

$

0.25

$

1,553,741

December 9, 2024

Quarterly

December 19, 2024

December 27, 2024

$

0.34

$

7,758,925

March 14, 2025

Quarterly

March 28, 2025

April 11, 2025

$

0.34

$

7,758,931

May 12, 2025

Quarterly

June 27, 2025

July 11, 2025

$

0.34

$

7,758,939

Dividend Reinvestment Plan

We have adopted an "opt out" DRIP for our stockholders. As a result, if we declare a dividend, then stockholders' cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically "opt out" of the DRIP so as to receive cash distributions. Stockholders who receive distributions in the form of shares of our common stock generally are subject to the same U.S. federal income tax consequences as are stockholders who elect to receive their distributions in cash.

During the six months ended June 30, 2025, the Company issued the following shares of common stock under the DRIP:

Declaration Date

Type

Record Date

Payment Date

Shares

March 14, 2025

Quarterly

March 28, 2025

April 11, 2025

22

During the six months ended June 30, 2024, the Company issued the following shares of common stock under the DRIP:

Declaration Date

Type

Record Date

Payment Date

Shares

March 8, 2024

Quarterly

March 20, 2024

March 28, 2024

8

May 9, 2024

Quarterly

June 20, 2024

June 28, 2024

15

Issuer Purchases of Equity Securities

We did not repurchase any of our equity securities during the six months ended June 30, 2025 or the fiscal year ended December 31, 2024.

Chicago Atlantic BDC Inc. published this content on August 14, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on August 14, 2025 at 11:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]